Pacific Biosciences Of California Shares Outstanding 2009-2019 | PACB

Pacific Biosciences Of California shares outstanding from 2009 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Pacific Biosciences Of California Annual Shares Outstanding
(Millions of Shares)
2018 135
2017 106
2016 89
2015 76
2014 70
2013 63
2012 56
2011 54
2010 10
2009 1
2008 0
2007 0
Pacific Biosciences Of California Quarterly Shares Outstanding
(Millions of Shares)
Q1 2019 151
Q4 2018 135
Q3 2018 135
Q2 2018 132
Q1 2018 124
Q4 2017 106
Q3 2017 116
Q2 2017 97
Q1 2017 93
Q4 2016 89
Q3 2016 92
Q2 2016 88
Q1 2016 84
Q4 2015 76
Q3 2015 80
Q2 2015 75
Q1 2015 74
Q4 2014 70
Q3 2014 71
Q2 2014 71
Q1 2014 68
Q4 2013 63
Q3 2013 66
Q2 2013 62
Q1 2013 57
Q4 2012 56
Q3 2012 56
Q2 2012 56
Q1 2012 55
Q4 2011 54
Q3 2011 54
Q2 2011 53
Q1 2011 53
Q4 2010 10
Q3 2010 1
Q2 2010 1
Q1 2010 1
Q4 2009
Q3 2009 1
Q4 2008
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.896B $0.079B
Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. The SMRT technology uses the natural processing power of enzymes, combined with specially designed reagents and detection systems, to record individual biochemical events as they occur. The Company's technology platform comprises of the SMRT cells, Phospholinked nucleotides and the PacBio RS (an instrument that conducts, monitors and analyzes single molecule biochemical reactions in real time). Its product will find its application in both research institutions and commercial companies, including genome centers, government and academic institutions, genomic service providers, pharmaceutical companies and agriculture companies. Pacific Biosciences of California, Inc. is headquartered in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $114.795B 25.11
Intuitive Surgical (ISRG) United States $60.437B 55.69
Edwards Lifesciences (EW) United States $39.565B 39.53
IDEXX Laboratories (IDXX) United States $24.500B 64.27
Fresenius Medical Care AG KGaA (FMS) Germany $23.376B 15.36
Teleflex (TFX) United States $15.415B 33.40
Olympus (OCPNY) Japan $14.976B 112.05
SONOVA HOLDING (SONVY) Switzerland $14.611B 0.00
Sysmex ADR (SSMXY) Japan $14.124B 38.08
DexCom (DXCM) United States $13.436B 263.52
Hologic (HOLX) United States $12.689B 20.41
STERIS (STE) Ireland $12.500B 30.23
Varian Medical Systems (VAR) United States $12.264B 31.29
ABIOMED (ABMD) United States $11.776B 71.64
Masimo (MASI) United States $8.149B 49.93
Penumbra (PEN) United States $6.046B 255.96
SARTORIUS AG (SARTF) Germany $5.850B 53.60
Elekta AB (EKTAY) Sweden $5.013B 37.78
Integra LifeSciences Holdings (IART) United States $4.611B 21.66
Globus Medical (GMED) United States $4.211B 26.26
Tandem Diabetes Care (TNDM) United States $3.649B 0.00
LivaNova (LIVN) United Kingdom $3.575B 23.30
Wright Medical Group (WMGI) Netherlands $3.346B 663.25
Cantel Medical (CMD) United States $3.304B 33.52
Glaukos (GKOS) United States $2.794B 0.00
Integer Holdings (ITGR) United States $2.633B 19.40
Nihon Kohden (NHNKY) Japan $2.397B 24.11
AVANOS MEDICAL, INC (AVNS) United States $1.909B 30.21
Nevro (NVRO) United States $1.896B 0.00
Inogen (INGN) United States $1.313B 29.07
OPKO Health (OPK) United States $1.299B 0.00
Silk Road Medical (SILK) United States $1.262B 0.00
Veracyte (VCYT) United States $1.208B 0.00
CryoLife (CRY) United States $1.122B 111.33
Accelerate Diagnostics (AXDX) United States $1.039B 0.00
Tactile Systems Technology (TCMD) United States $1.019B 150.31
ORTHOFIX MEDICAL INC (OFIX) United States $0.975B 28.24
Mesa Laboratories (MLAB) United States $0.902B 42.40
Luminex (LMNX) United States $0.899B 117.53
ViewRay (VRAY) United States $0.896B 0.00
Natus Medical (BABY) United States $0.877B 20.31
AngioDynamics (ANGO) United States $0.802B 26.27
AxoGen (AXGN) United States $0.787B 0.00
Fluidigm (FLDM) United States $0.780B 0.00
Quotient (QTNT) Switzerland $0.696B 0.00
Intersect ENT (XENT) United States $0.634B 0.00
Corindus Vascular Robotics (CVRS) United States $0.542B 0.00
OrthoPediatrics (KIDS) United States $0.531B 0.00
Si-Bone (SIBN) United States $0.493B 0.00
GenMark Diagnostics (GNMK) United States $0.358B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.344B 18.44
Accuray (ARAY) United States $0.320B 0.00
RTI Surgical (RTIX) United States $0.307B 37.82
Semler Scientific (SMLR) United States $0.304B 60.26
TransEnterix (TRXC) United States $0.296B 0.00
SeaSpine Holdings (SPNE) United States $0.240B 0.00
Neuronetics (STIM) United States $0.234B 0.00
Alphatec Holdings (ATEC) United States $0.220B 0.00
ConforMIS (CFMS) United States $0.216B 0.00
IRadimed (IRMD) United States $0.206B 39.19
CRH Medical (CRHM) Canada $0.201B 69.75
Sientra (SIEN) United States $0.184B 0.00
Stereotaxis (STXS) United States $0.170B 0.00
Second Sight Medical Products (EYES) United States $0.107B 0.00
Sensus Healthcare (SRTS) United States $0.089B 0.00
Ekso Bionics Holdings (EKSO) United States $0.086B 0.00
Vermillion (VRML) United States $0.082B 0.00
EDAP TMS S.A (EDAP) France $0.077B 0.00
T2 Biosystems (TTOO) United States $0.076B 0.00
Covalon Technologies (CVALF) Canada $0.073B 0.00
Apollo Endosurgery (APEN) United States $0.066B 0.00
Spectral Diagnostics (EDTXF) Canada $0.064B 0.00
Helius Medical Technologies (HSDT) United States $0.053B 0.00